- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Virax Biolabs Group Ltd (VRAX)
The Virax Biolabs share price today is 2.8900, view NASDAQ VRAX stock exchange data. Track the latest Virax Biolabs share price with real-time updates on VRAX stock performance including market cap, day range, 52-week range and dividend yield. Access VRAX charts, earnings dates and analyst estimates to support your investment decisions.
2.8900
+0.0700(+2.48%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.8385
2.8900
52 wk Range
2.5000
21.7500
VRAX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.83852.8900
52 wk Range
2.500021.7500
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VRAX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
25.0000
Upside
+765.05%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 25.0000
(+765.05% Upside)
Earnings
Latest Release
06-07-2026
EPS / Forecast
-4.45 / --
Revenue / Forecast
10.82K / --
Compare VRAX to Peers and Sector
Metrics to compare | VRAX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVRAXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.4x | −4.6x | −0.4x | |
PEG Ratio | −0.01 | 0.26 | 0.00 | |
Price/Book | 0.3x | 3.4x | 2.6x | |
Price / LTM Sales | 180.9x | 2.6x | 3.1x | |
Upside (Analyst Target) | - | 21.5% | 48.4% | |
Fair Value Upside | Unlock | −4.4% | 6.5% | Unlock |
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only portfolio of peptide pool ELISpot plates and related immune reagents. In addition, the company is involved in research and development activities and the provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, academic institutions, contract research organizations, biopharmaceutical companies, independent laboratories, and distributors. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, United Kingdom.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Virax Biolabs (VRAX) Share Price Today?
The Virax Biolabs share price today is 2.8900.
What is the current Virax Biolabs (VRAX) share price and day range?
As of 14-08-2026, the Virax Biolabs share price is 2.8900, with a previous close of 2.8200. The share price has ranged from 2.8385 to 2.8900 today, while the 52-week range spans from 2.5000 to 21.7500.
What Is the Virax Biolabs Market Cap?
As of today, Virax Biolabs market cap is 2.2700M.
What Is the Virax Biolabs (VRAX) Share Price Target?
The average 12-month share price target for Virax Biolabs is 25.0000, with a high estimate of 25 and a low estimate of 25. 1 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +765.05% Upside potential.
What Is Virax Biolabs's Earnings Per Share (TTM)?
The Virax Biolabs EPS (TTM) is -12.6400.
From a Technical Analysis Perspective, Is VRAX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
What Stock Exchange Does Virax Biolabs Trade On?
Virax Biolabs is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Virax Biolabs?
The stock symbol for Virax Biolabs is "VRAX."
How Many Times Has Virax Biolabs Stock Split?
Virax Biolabs has split 2 times.
How Many Employees Does Virax Biolabs Have?
Virax Biolabs has 26 employees.
What Is the VRAX Premarket Price?
VRAX's last pre-market stock price is 2.8700. The pre-market share volume is 5,820.0000, and the stock has changed by 0.0500, or 1.7700%.
What Is the VRAX After Hours Price?
VRAX's last after hours stock price is 2.8000, the stock has changed by -0.0200, or -0.7100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.